June 14, 2021
Sustainability Topics

Tokyo, Japan (June 14, 2021) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Toshiaki Sai), has awarded its 14th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.

Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.

The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 16, 2021.

*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 14th Japan Research Foundation for Clinical Pharmacology Research Award




Research theme

Ogawa Youichi

Graduate School of Medicine, the Department of Dermatology, University of Yamanashi

Urinary lipocalin-2 could be a promising biomarker to predict the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis

Sakata-Yamagimoto Mamiko

Department of Hematology, Faculty of Medicine, University of Tsukuba

Therapeutic approach targeting aberrant activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma

Zamami Yoshito

Department of Clinical Pharmacology and Therapeutics, Institute of Biomedical Sciences, Tokushima University Graduate School

Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data to facilitate drug repositioning

Suzuki Yosuke

Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University

Physiologic factors associated with OATP1B activity in vivo

Fukudo Masahide

Department of Pharmacy, Sapporo Medical University Hospital

Evaluation of pharmacokinetics/pharmacodynamics and anti-drug antibody of PD-1 blockers